百洋医药与君信就安博美签署经销协议

Core Viewpoint - Baiyang Pharmaceutical has signed a distribution agreement with Guangzhou Junxin Pharmaceutical, granting exclusive rights to promote, sell, and distribute the product Anbomei in specific markets within China, excluding Hong Kong, Macau, and Taiwan [1] Group 1 - The agreement was signed on November 4, and it outlines the rights and obligations of both parties [1] - Junxin Pharmaceutical is a subsidiary of Jet Bailing (Asia Pacific) Limited, which operates sales in China through Junxin [1] - Baiyang Pharmaceutical aims to provide a comprehensive commercialization solution for Anbomei, enhancing product accessibility and brand value [1]